Telomir Pharmaceuticals Secures $5.6 Million Financing

Telomir Pharmaceuticals Inc. announced it has secured $5.6 million in financing, strengthening its capital position as the company advances Telomir-Zn into clinical development. The financing involved an increase in investment from billionaire entrepreneur John Paul DeJoria.